Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, G; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R.
Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial
BREAST. 2009; 18: S59-S59.
Doi: 10.1016/S0960-9776(09)70187-0
Web of Science
FullText
FullText_MUG